‘Electroceuticals’ are expanding psychiatry’s toolbox
Washington Post,
Doctors are turning to new technology for patients with treatment-resistant depression and OCD.
Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study
Overview of attention for article published in Journal of Psychopharmacology, January 2024
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (88th percentile)
-
Average Attention Score compared to outputs of the same age and source
Readers on
- mendeley
- 84 Mendeley